In-depth cytogenetic and immunohistochemical analysis in a real world cohort - reconsidering the role of primary and secondary aberrations in multiple myeloma
Haematologica. 2024 Jan 1;109(1):318-324.
doi: 10.3324/haematol.2023.283142.
1 Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg.
2 Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg, Germany; Clinical Trials Unit, Faculty of Medicine, University of Freiburg, Freiburg.
3 Department of Pathology, Faculty of Medicine, University of Freiburg, Freiburg.
4 Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg. [email protected].